| [1] |
WANG Xin, LIU Weiying, WU Chen, KAI Jinjun, LIANG Xuejie, CHANG Yingxuan.
Metformin regulates AMPK/SREBP-1 pathway and its clinical application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1049-1054.
|
| [2] |
DU Jie, ZHAO Tingting, WANG Dalong, CHEN Xiaodong, LIU Kexin, WU Jingjing.
Role and research progress of CYP46A1 in neurodegenerative diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 925-935.
|
| [3] |
LIU Xing, LU Xiaoran, WU Ying, YU Haitao, WANG Xiaomin.
Ethical analysis and countermeasures of artificial intelligence application in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 322-327.
|
| [4] |
YANG Jie, CAO Junli, LIU He.
Research progress on the effect of noninvasive neuromodulation technique on patients with postoperative sleep disturbances after general anesthesia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1322-1332.
|
| [5] |
SHI Yingzi, ZHAO Yang.
Impact of China-US drug regulatory incentives on local innovative drug simultaneous development in multiple countries: An empirical study based on zanubrutinib
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 560-569.
|
| [6] |
ZHANG Qian, HU Wei, YU Bin, QIN Huiling, CHEN Mingzhuang, LU Chao.
Information construction of drug clinical trials based on literature analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 182-189.
|
| [7] |
ZHANG Yanping, PEI Tong, HU Chaoying, ZHANG Lan.
Brief analysis on the measures for the management of instruments and equipment in phase Ⅰ drug clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 890-894.
|
| [8] |
ZHANG Jisheng, HUANG Kai, CHU Nannan, HE Qing.
Application and progress of pharmacokinetics study in bioequivalence evaluation of orally inhaled drug products
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1295-1308.
|
| [9] |
ZHANG Xiaoling，GUAN Qiaobin，YANG Yi, GUO Li，HAN Chenyang.
Effect of interleukin 12A on proliferation and differentiation of CD4+CD25+Foxp3+Treg
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 496-502.
|
| [10] |
ZONG Sidou, ZHANG Hong.
Research progress of MRP3 and MRP4 transporters in tumor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 327-331.
|
| [11] |
HE Hesheng, JIN Xiaoke, XU Youhai, YANG Yuqiong, LIU Shanhao, QI Jing.
Number of regulatory B cells in peripheral blood of patients with autoimmune hemolytic anemia and its clinical signifcance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 329-332.
|
| [12] |
PENG Peng, YUAN Wei'an, HU Yihui, TANG Jie, JIANG Jian.
Analysis of regulatory issues of adverse events in drug clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 78-82.
|
| [13] |
SHEN Chen, LI Yunman, XIA Nian, XU Dan, HAN Dan, CHEN Shijie.
Research on the inhibition of Treg cells on MMP-9 in rheumatoid arthritis with acute cerebral ischemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 831-840.
|
| [14] |
YU Shan-shan, ZHANG Zheng-fu, LI Zheng-qi.
Investigation and countermeasures to the current status of the generics quality consistency evaluation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(1): 118-120.
|
| [15] |
YU Wan-jun, WANG Hua-ying, WENG Yue-song, SONG Yan-jin, GU Xiao, YING Hua-juan.
Variation of CD4＋Foxp3＋ regulatory T cells in sub-acute and chronic cigarette smoke exposure in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 601-606.
|
